NXTCL — NextCell Pharma AB Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapSucker Stock

Annual balance sheet for NextCell Pharma AB, fiscal year end - August 31st, SEK millions except per share, conversion factor applied.

	2020 August 31st	2021 August 31st	2022 August 31st	2023 August 31st	2024 August 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	SAS	SAS	SAS	SAS	SAS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	22	139	97.1	50	46.8
Net Total Accounts Receivable
Net Total Receivables	1.27	1.7	2.71	3.58	3.12
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	26	146	107	67.3	60.6
Net Property, Plant And Equipment	2.61	2.9	9.9	13.6	12.7
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	29.8	156	125	88.8	81.3
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	2.17	3.96	6.93	10.1	9.87
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	3.56	5.53	9.12	13.1	13.7
Common Stock
Retained Earnings (Accumulated Deficit)
Total Equity	26.2	150	116	75.7	67.6
Total Liabilities & Shareholders' Equity	29.8	156	125	88.8	81.3
Total Common Shares Outstanding